My Policy Hub

Improving health is our policy

  • Dashboard
  • Impact Insights
  • Issues
  • ACA Now
  • Search
  • Contact
  • Dashboard
  • Impact Insights
  • Issues
  • ACA Now
  • Search
  • Contact

ACA Now

4107 - Coverage of Comprehensive Tobacco Cessation Services for Pregnant Women in Medicaid

 
Implementation Status 
Statutory Text 

Summary

Mandates that States cover, under their respective Medicaid programs, comprehensive tobacco cessation services for women who are pregnant (including prescription and non-prescription tobacco cessation agents) and non-pharmaceutical treatments, without cost-sharing.

#Prevention, #Wellness, #Women’s Health

Implementation Status

 
Summary 
Statutory Text 

2011

In the summer of 2011, CMS issued final guidance pursuant to this provision, which is delineated on CMS’ webpage on this and other related ACA initiatives.

2014

On March 27, 2014, the CDC issued a report (press release) documenting “uneven progress in expanding state Medicaid coverage for smoking cessation,” and noting that “more smokers would quit if state Medicaid programs covered more cessation treatments and removed barriers to coverage.”

Statutory Text

 
Implementation Status 
Summary 

SEC. 4107. COVERAGE OF COMPREHENSIVE TOBACCO CESSATION SERVICES FOR PREGNANT WOMEN IN MEDICAID. (a) REQUIRING COVERAGE OF COUNSELING AND PHARMACOTHERAPY FOR CESSATION OF TOBACCO USE BY PREGNANT WOMEN.

—Section 1905 of the Social Security Act (42 U.S.C. 1396d), as amended by sections 2001(a)(3)(B) and 2303, is further amended— (1) in subsection (a)(4)— (A) by striking ‘‘and’’ before ‘‘(C)’’; and (B) by inserting before the semicolon at the end the following new subparagraph: ‘‘; and (D) counseling and pharmacotherapy for cessation of tobacco use by pregnant women (as defined in subsection (bb))’’; and (2) by adding at the end the following: ‘‘(bb)(1) For purposes of this title, the term ‘counseling and pharmacotherapy for cessation of tobacco use by pregnant women’ means diagnostic, therapy, and counseling services and pharmacotherapy (including the coverage of prescription and nonprescription tobacco cessation agents approved by the Food and Drug Administration) for cessation of tobacco use by pregnant women who use tobacco products or who are being treated for tobacco use that is furnished— ‘‘(A) by or under the supervision of a physician; or ‘‘(B) by any other health care professional who— ‘‘(i) is legally authorized to furnish such services under State law (or the State regulatory mechanism provided by State law) of the State in which the services are furnished; and ‘‘(ii) is authorized to receive payment for other services under this title or is designated by the Secretary for this purpose. ‘‘(2) Subject to paragraph (3), such term is limited to— ‘‘(A) services recommended with respect to pregnant women in ‘Treating Tobacco Use and Dependence: 2008 Update: A Clinical Practice Guideline’, published by the Public Health Service in May 2008, or any subsequent modification of such Guideline; and ‘‘(B) such other services that the Secretary recognizes to be effective for cessation of tobacco use by pregnant women. ‘‘(3) Such term shall not include coverage for drugs or biologicals that are not otherwise covered under this title.’’. (b) EXCEPTION FROM OPTIONAL RESTRICTION UNDER MEDICAID PRESCRIPTION DRUG COVERAGE.—Section 1927(d)(2)(F) of the Social Security Act (42 U.S.C. 1396r–8(d)(2)(F)), as redesignated by section 2502(a), is amended by inserting before the period at the end the following: ‘‘, except, in the case of pregnant women when recommended in accordance with the Guideline referred to in section 1905(bb)(2)(A), agents approved by the Food and Drug Administration under the over-the-counter monograph process for purposes of promoting, and when used to promote, tobacco cessation’’. (c) REMOVAL OF COST-SHARING FOR COUNSELING AND PHARMACOTHERAPY FOR CESSATION OF TOBACCO USE BY PREGNANT WOMEN.— (1) GENERAL COST-SHARING LIMITATIONS.—Section 1916 of the Social Security Act (42 U.S.C. 1396o) is amended in each of subsections (a)(2)(B) and (b)(2)(B) by inserting ‘‘, and counseling and pharmacotherapy for cessation of tobacco use by pregnant women (as defined in section 1905(bb)) and covered outpatient drugs (as defined in subsection (k)(2) of section 1927 and including nonprescription drugs described in subsection (d)(2) of such section) that are prescribed for purposes of promoting, and when used to promote, tobacco cessation by pregnant women in accordance with the Guideline referred to in section 1905(bb)(2)(A)’’ after ‘‘complicate the pregnancy’’. (2) APPLICATION TO ALTERNATIVE COST-SHARING.—Section 1916A(b)(3)(B)(iii) of such Act (42 U.S.C. 1396o–1(b)(3)(B)(iii)) is amended by inserting ‘‘, and counseling and pharmacotherapy for cessation of tobacco use by pregnant women (as defined in section 1905(bb))’’ after ‘‘complicate the pregnancy’’. (d) EFFECTIVE DATE.—The amendments made by this section shall take effect on October 1, 2010.

Browse ACA Titles

  • I-Quality, Affordable Health Care for all Americans
  • II-Role of Public Programs
  • III-Improving the Quality and Efficiency of Health Care
  • IV-Prevention of Chronic Disease and Improving Public Health
  • V-Health Care Workforce
  • VI-Transparency and Program Integrity
  • VII-Improving Access to Innovative Medical Therapies
  • VIII-Community Living Assistance Services and Supports (CLASS ACT)
  • IX-Revenue Provisions

ABOUT

  • Home
  • About Policy Hub
  • Free Newsletter
  • Team
  • Mission and Values
  • Contact Us

Contact Us

Impact Health Policy Partners 1301 K Street, NW, Suite 300W
Washington, D.C. 20005

(202) 309-0796
Contact Us

Copyright © 2025 ‐ Impact Health Policy Partners ‐ All Rights Reserved ‐ Privacy Policy ‐ Terms and Conditions ‐ Log in